All properties in NCIT
Label | Id | Description |
---|---|---|
Gene_Product_Has_Structural_Domain_Or_Motif | NCIT_R50 | [A role used specify information about protein domains or motifs present in a protein that can give insight into protein function. The domain and range for this role are 'Gene Product' and 'Anatomic Structure, System, or Substance', respectively.] |
Gene_Product_Is_Biomarker_Of | NCIT_R47 | [A role used to indicate that presence of a gene product may contribute to clinical diagnosis, treatment selection, or prediction of clinical outcome. The domain and range for this role are 'Gene Product' and 'Disease, Disorder or Finding', respectively.] |
Gene_Product_Is_Biomarker_Type | NCIT_R42 | [A role used to designate the type of biomarker a gene product is; it points to a small tree of biomarker types (e.g., Disease Marker, Metabolic Marker, Prognostic Marker). The domain and range for this role are 'Gene Product' and 'Diagnostic or Prognostic Factor', respectively.] |
Gene_Product_Is_Element_In_Pathway | NCIT_R131 | [A role used to assert a relationship between a gene product and a biochemical pathway in which it participates. This relationship is used only when a gene product has been implicated in a pathway by the curated source (Biocarta, KEGG or PID). The domain and range for this role are 'Gene Product' and 'Biochemical Pathway', respectively.] |
Gene_Product_Is_Physical_Part_Of | NCIT_R51 | [A role used to indicate that a gene product normally functions as a component of a "functional complex". Both the domain and range for this role are 'Gene Product'.] |
Gene_Product_Malfunction_Associated_With_Disease | NCIT_R48 | [A role used to indicate that molecular abnormalities in a gene product may be associated with the manifestation of a disease. The role is used to assert a link between a gene product and a disease when the association is considered to have clinical relevance. The domain and range for this role are 'Gene Product' and 'Disease, Disorder or Finding', respectively.] |
Gene_Product_Plays_Role_In_Biological_Process | NCIT_R53 | [A role used to assert that a gene product participates in a specific biological process. The domain and range for this role are 'Gene Product' and 'Biological Process', respectively.] |
Gene_Product_Sequence_Variation_Encoded_By_Gene_Mutant | NCIT_R179 | [A role used to indicate that a gene product sequence variation is encoded by a specific gene mutant. The domain and range for this role are 'Gene Product Sequence Variation' and 'Gene Mutant', respectively.] |
Gene_Product_Variant_Of_Gene_Product | NCIT_R182 | [A role used to indicate that a gene product sequence variation is related to a wild-type gene product. The domain and range for this role are 'Gene Product Sequence Variation' and 'Gene Product', respectively.] |
HGNC_ID | NCIT_P369 | [A property representing that a concept in the 'Gene' branch of the NCI thesaurus maps to a HUGO Gene Nomenclature Committee (HGNC) certified gene.] |
Has_CDRH_Parent | NCIT_A10 | [An association created to allow the source CDRH to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which they are the contributing source.] |
Has_CTCAE_5_Parent | NCIT_A15 | [An association created to allow the source CTCAE 5.0 to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which CTCAE is the contributing source.] |
Has_Data_Element | NCIT_A12 | [An association created to relate a data element concept to the codelist term that is used to bundle its subset of valid value concepts.] |
Has_Free_Acid_Or_Base_Form | NCIT_A6 | [An association that connects the salt form of a drug with its free acid or free base.] |
Has_INC_Parent | NCIT_A16 | [An association created to allow the source INC to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which they are the contributing source.] |
Has_NICHD_Parent | NCIT_A11 | [An association created to allow the source NICHD to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which they are a contributing source.] |
Has_Pharmaceutical_Administration_Method | NCIT_A19 | [An association that specifies the methods by which a pharmaceutical product is intended to be administered to the patient. The target value should belong to the EDQM-HC Administration Method Terminology.] |
Has_Pharmaceutical_Basic_Dose_Form | NCIT_A18 | [An association that specifies the category of the pharmaceutical dose form, used to group together related pharmaceutical dose forms. The target value should belong to the EDQM-HC Basic Dose Form Terminology.] |
Has_Pharmaceutical_Intended_Site | NCIT_A20 | [An association that specifies the general body sites at which a pharmaceutical product is intended to be administered. The target value should belong to the EDQM-HC Intended Site of Administration Terminology.] |
Has_Pharmaceutical_Release_Characteristics | NCIT_A21 | [An association that specifies the timing by which an active ingredient is made available in the body after administration of the pharmaceutical product, in comparison with a conventional, direct release of the active ingredient. The target value should belong to the EDQM-HC Release Characteristics Terminology.] |